Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunex -- Ignore unavailable to you. Want to Upgrade?

To: Jane4IceCream who wrote (559)	9/1/2001 12:21:02 PM
From: Alphapenguin	Read Replies (1) \| Respond to of 656

Jane, aside from the obvious reasons, including the entire biotech sector being presently undervalued, I trade on a combination of individual issue fundamentals, but with special emphasis on technical analysis. See this link and you'll know what I mean: clearstation.com I did buy 500 shares at Friday's close, expecting a nice post-Labor Day rally, but one rule that I do try to follow is to not have any open individual positions at the end of the day, as my LTBH positions are all in mutual funds. Simply too many unknown variables that can take a chunk out of an overnight holding. There are always exceptions such as IMNX, and it does offer the volatility to make profitable day trades. In the final analysis, I think we will both prosper from IMNX. Curious about the special meeting called for later this month, though. Also, see my posts under "alphapenguin" on the RB IMNX thread. Thx for the note. All the best to you. -Opus